Question 1

What are the potential side effects of PF-06651600 and PF-06700841?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I receive a placebo, and how will that affect my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the study, including any tests or procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects clinical trial (NCT03715829). Contact the study team or your healthcare provider for specific answers.

What this study is about